根據一篇尚未接受同行審查的文章(Ref1),Moderna及輝端疫苗兩者在人體所產生的抗體數量並無大分別,而且抗體所針對病毒的位置,亦跟自然感染武肺人士所產生的抗體相同。532Please respect copyright.PENANAQ3iubh2D01
532Please respect copyright.PENANAmIfSRltaex
注射兩者第二劑疫苗的3-14星期後,其抗體數量約與自然感染人士1.3個月後的數量接近。532Please respect copyright.PENANAXHqmZghfuN
532Please respect copyright.PENANAg9CD3gogqU
奈何的是,疫苗所產生的抗體,其應對英國/南非變種的能力明顯有所銳弱。根據抗體種類的不同,有一些抗體應對變種病毒的能力至少被銳弱了十倍以上有多。532Please respect copyright.PENANAaPANfBkObn
532Please respect copyright.PENANAsQFQxLqKAO
同時間,把武肺病毒與疫苗抗體共同培植的話,能生存下來的武肺病毒亦出現與英國及南非變種一樣的排序,變相逆向證明疫苗或自然感染未變種病毒人士的抗體沒能有效應對最新的南非/英國或旗下牽伸的各種變種。532Please respect copyright.PENANAv58gaZuZ21
532Please respect copyright.PENANAwQSkVYV1J3
若然屬實,Moderna/輝端疫苗很有可能要更新第二代作出應對。532Please respect copyright.PENANAhorKIq2q6S
532Please respect copyright.PENANA101uCIyXXp
至於科興及國藥疫苗會否同屬一命運,則尚未清楚,但在理論層面上,滅活疫苗應對變種的可能性會較mRNA疫苗更高。532Please respect copyright.PENANA0DB5YYcG8m
532Please respect copyright.PENANAowCB5P8HdP
不過理論歸理論,一切尚需實驗證據確實。532Please respect copyright.PENANApkGxI6Xos6
532Please respect copyright.PENANAPCiLtYhlpv
532Please respect copyright.PENANA9KYH7d2Iix
532Please respect copyright.PENANAnt4U7H87VE
Ref1:https://www.biorxiv.org/content/10.1101/2021.01.15.426911v1.full.pdf532Please respect copyright.PENANA2pwrLo4GTt